頁籤選單縮合
題 名 | Carbamazepine藥品使用評估=Drug Utilization Evaluation of Carbamazepine |
---|---|
作 者 | 鄭淑文; 盧令瑜; 蔡俊佳; | 書刊名 | 藥學雜誌 |
卷 期 | 30:2=119 2014.06[民103.06] |
頁 次 | 頁75-79 |
分類號 | 418.21 |
關鍵詞 | 藥品使用評估; 不良反應; Carbamazepine; Drug utilization evaluation; Adverse drug reactions; |
語 文 | 中文(Chinese) |
中文摘要 | 根據國內統計1999-2010年所通報的不良反應案例中,carbamazepine 通報量中, 核准之適應症外使用 (off-label use) 有27.1%,適應症使用不明有46.4%。1999-2007 年所通報的不良反應案例中,carbamazepine 排名皆在前10名內。國內目前尚無探討 分析 carbamazepine 用藥評估之相關研究,國外研究只限於抗癲癎用藥用於癲癎患者 用藥評估。本研究主要目的乃藉由藥品使用評估指引,針對 carbamazepine 用藥合理 性、用藥安全性、用藥有效性作一全面性探討,以提供日後更合理、更有效益的用藥 參考,以落實臨床藥學服務,確保病人用藥安全。 |
英文摘要 | According to cases of adverse drug reactions reported from domestic statistics during 1999-2010, the amounts of notified cases with off-label use and indications unknown are 27.1% and 46.4% respectively. Carbamazepine had ranked in the top 10 cases notified with adverse drug reactions during 1999-2007. Currently, there is still no related analytical research of carbamazepine medication assessment domestically and foreign researches are merely confined to the assessment of the antiepileptic drug medication for epilepsy patients. For providing a more effective medication reference to the implementation of clinical pharmacy services and the warrant for patient medication safety in the future, this study is to comprehensively explore the medication rationality, the medication safety and the medication effectiveness of carbamazepine through drug utilization evaluation. |
本系統中英文摘要資訊取自各篇刊載內容。